Outpatient Chemotherapy and Infusion Center

Submit request or call to make an appointment.

The Norton Children’s Infusion Center, part of Norton Children’s Cancer Institute, affiliated with the UofL School of Medicine, provides families with easy access to chemotherapy treatment and other medications without having to spend a night in the hospital. The center focuses on children, but we also administer infusions to adults.

In addition to chemotherapy, our providers also specialize in delivering immunomodulating therapy — medications that either stimulate or suppress the immune system to treat various conditions.

The experienced team of certified nurses works together to provide care based on each patient’s specific needs. To ensure a relaxing environment, we provide well-equipped patient rooms complete with:

  • Hospital beds or comfortable recliners
  • Chairs for friends, family members and visitors
  • A comfortable waiting area

Services include:

  • Outpatient chemotherapy treatments in conjunction with the cancer care team
  • Intravenous infusion therapy for patients with specific needs
  • Blood transfusions
  • Assistance with lumbar punctures and bone marrow aspirations
  • Monthly port access
  • Red blood cell exchange, an effective therapy for sickle cell disease in which damaged red cells are removed and replaced with healthy red blood cells
  • White cell depletion, which uses apheresis to remove white blood cells when levels are dangerously high
  • Red blood cell depletion to remove excess red blood cells using apheresis
  • Photopheresis for graft-versus-host disease, solid organ transplant rejections, autoimmune diseases such as Crohn’s disease and ulcerative colitis, and some pretransplant conditioning regimens
  • Peripheral stem cell harvesting, which collects stem cells from blood using apheresis

Related Stories

Norton Children’s nationally ranked by U.S. News & World Report
After anemia and leukemia, this little girl is ready to move to the beat 
Norton Children’s names new pediatric cancer chief
Osteosarcoma isn’t slowing down this Kentucky teen